266 related articles for article (PubMed ID: 33708423)
1. CD276 suppresses CAR-T cell function by promoting tumor cell glycolysis in esophageal squamous cell carcinoma.
Yue G; Tang J; Zhang L; Niu H; Li H; Luo S
J Gastrointest Oncol; 2021 Feb; 12(1):38-51. PubMed ID: 33708423
[TBL] [Abstract][Full Text] [Related]
2. Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models.
Xuan Y; Sheng Y; Zhang D; Zhang K; Zhang Z; Ping Y; Wang S; Shi X; Lian J; Liu K; Zhang Y; Li F
Transl Oncol; 2021 Aug; 14(8):101138. PubMed ID: 34052626
[TBL] [Abstract][Full Text] [Related]
3. CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs.
Xiong G; Chen Z; Liu Q; Peng F; Zhang C; Cheng M; Ling R; Chen S; Liang Y; Chen D; Zhou Q
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38724465
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma.
Lin X; Guan T; Xu Y; Li Y; Lin Y; Chen S; Chen Y; Wei X; Li D; Cui Y; Lin Y; Sun P; Guo J; Li C; Gu J; Yang W; Zeng H; Ma C
Front Immunol; 2024; 15():1337489. PubMed ID: 38566988
[TBL] [Abstract][Full Text] [Related]
5. CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
Timpanaro A; Piccand C; Dzhumashev D; Anton-Joseph S; Robbi A; Moser J; Rössler J; Bernasconi M
J Exp Clin Cancer Res; 2023 Nov; 42(1):293. PubMed ID: 37924157
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.
Grote S; Ureña-Bailén G; Chan KC; Baden C; Mezger M; Handgretinger R; Schleicher S
Cells; 2021 Apr; 10(5):. PubMed ID: 33925968
[TBL] [Abstract][Full Text] [Related]
7. EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma.
Shi H; Yu F; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Xu R; Jiang M; Shi J
J Thorac Dis; 2018 May; 10(5):2779-2788. PubMed ID: 29997940
[TBL] [Abstract][Full Text] [Related]
8. Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma.
Cheng C; Cui H; Liu H; Wu Y; Ding N; Weng Y; Zhang W; Cui Y
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551506
[TBL] [Abstract][Full Text] [Related]
9. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
[TBL] [Abstract][Full Text] [Related]
10. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation.
Zhang Q; Liu Q; Zheng S; Liu T; Yang L; Han X; Lu X
J Cancer; 2021; 12(16):4830-4840. PubMed ID: 34234853
[No Abstract] [Full Text] [Related]
11. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
12. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
13. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
[TBL] [Abstract][Full Text] [Related]
14. Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment.
Li R; Huang B; Tian H; Sun Z
Front Oncol; 2022; 12():1096717. PubMed ID: 36698392
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.
Bao R; Wang Y; Lai J; Zhu H; Zhao Y; Li S; Li N; Huang J; Yang Z; Wang F; Liu Z
Mol Pharm; 2019 Jan; 16(1):339-348. PubMed ID: 30452269
[TBL] [Abstract][Full Text] [Related]
16. Effect of tumor CD276 expression on infiltrating immune cells and clinicopathological features of prostate cancer.
Liu J; Kadier A; Guo Y; Zhang W; Chen H; Zhang Z; Guo C; Zhang Y; Bao M; Geng J; Zhang J; Mao S; Yao X
Prostate Cancer Prostatic Dis; 2023 Jun; ():. PubMed ID: 37380802
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
[TBL] [Abstract][Full Text] [Related]
20. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
